VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 122 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,226 | +209.6% | 283,804 | +429.2% | 0.01% | +100.0% |
| Q4 2022 | $396 | -100.0% | 53,627 | -58.7% | 0.01% | -57.1% |
| Q3 2022 | $1,282,000 | +102.5% | 129,785 | +123.4% | 0.01% | +100.0% |
| Q2 2022 | $633,000 | +65.3% | 58,093 | +137.6% | 0.01% | +250.0% |
| Q4 2021 | $383,000 | +1.6% | 24,450 | +39.1% | 0.00% | -33.3% |
| Q2 2021 | $377,000 | -16.8% | 17,571 | -41.9% | 0.00% | -40.0% |
| Q1 2021 | $453,000 | +319.4% | 30,226 | +168.0% | 0.01% | +66.7% |
| Q3 2020 | $108,000 | -66.6% | 11,279 | -60.1% | 0.00% | -70.0% |
| Q2 2020 | $323,000 | +29.7% | 28,282 | +86.4% | 0.01% | -9.1% |
| Q4 2019 | $249,000 | +88.6% | 15,174 | +44.8% | 0.01% | -82.3% |
| Q2 2015 | $132,000 | – | 10,477 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |